Apellis Pharmaceuticals (APLS) Insider Trading & Ownership $32.51 -4.22 (-11.49%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)13Amount OfInsider Selling(Last 12 Months)$34.73 M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Ad Monument Traders AllianceDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shocking way to take 100% certain events (mandated by the U.S. Government)...Check Out The Data NOW Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/16/2024A. Sinclair DunlopDirectorSell37,000$36.23$1,340,510.00 6/21/2024A. Sinclair DunlopDirectorSell37,000$39.24$1,451,880.00 5/8/2024Pascal DeschateletsInsiderSell78,907$42.35$3,341,711.45 4/8/2024Pascal DeschateletsInsiderSell69,107$54.17$3,743,526.19 4/1/2024Timothy Eugene SullivanCFOSell4,000$58.66$234,640.00 3/19/2024A. Sinclair DunlopDirectorSell18,681$57.18$1,068,179.58 ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>>3/18/2024Mark Jeffrey DelongInsiderSell9,913$56.90$564,049.70 3/15/2024James George ChopasCAOSell184$56.46$10,388.64 3/13/2024Nur NicholsonInsiderSell11,220$57.56$645,823.20 3/1/2024Cedric FrancoisCEOSell250,000$64.11$16,027,500.00 3/1/2024Timothy Eugene SullivanCFOSell6,000$63.22$379,320.00 2/12/2024Adam J TownsendInsiderSell1,148$67.77$77,799.96 2/12/2024Cedric FrancoisCEOSell3,962$67.77$268,504.74 2/12/2024David O WatsonGeneral CounselSell781$67.77$52,928.37 2/12/2024Timothy Eugene SullivanCFOSell1,431$67.77$96,978.87 1/29/2024Cedric FrancoisCEOSell2,843$64.14$182,350.02 1/29/2024David O WatsonGeneral CounselSell906$64.14$58,110.84 1/29/2024Nur NicholsonInsiderSell835$64.14$53,556.90 1/22/2024Adam J TownsendInsiderSell3,413$65.00$221,845.00 1/22/2024Cedric FrancoisCEOSell13,431$65.00$873,015.00 1/22/2024David O WatsonGeneral CounselSell4,184$65.00$271,960.00 1/22/2024James George ChopasCAOSell1,061$65.00$68,965.00 1/22/2024Timothy Eugene SullivanCFOSell3,551$65.00$230,815.00 1/16/2024Cedric FrancoisCEOSell7,851$66.81$524,525.31 1/16/2024David O WatsonGeneral CounselSell4,240$66.81$283,274.40 1/16/2024James George ChopasCAOSell864$66.81$57,723.84 1/16/2024Jeffrey EiseleInsiderSell438$66.81$29,262.78 1/16/2024Timothy Eugene SullivanCFOSell2,235$66.81$149,320.35 1/4/2024Caroline BaumalInsiderSell2,751$60.05$165,197.55 12/26/2023Jeffrey EiseleInsiderSell68$57.86$3,934.48 12/19/2023David O WatsonGeneral CounselSell3,905$57.23$223,483.15 12/1/2023Lukas ScheiblerInsiderSell10,000$60.00$600,000.00 11/21/2023Cedric FrancoisCEOSell5,000$48.80$244,000.00 11/17/2023Alec MachielsDirectorSell1,250$47.74$59,675.00 11/8/2023Pascal DeschateletsInsiderSell12,000$47.27$567,240.00 10/23/2023James George ChopasCAOSell132$46.04$6,077.28 10/23/2023Mark Jeffrey DelongInsiderSell131$46.04$6,031.24 10/17/2023Alec MachielsDirectorSell1,250$48.50$60,625.00 10/9/2023Pascal DeschateletsInsiderSell12,000$40.38$484,560.00 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 6.80% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,947,909.58), Adam J Townsend ($1,790,544.96), Alec Machiels ($922,000.00), Caroline Baumal ($165,197.55), Cedric Francois ($32,763,087.07), David O Watson ($1,655,486.56), Federico Grossi ($413,525.00), James George Chopas ($165,872.49), Jeffrey Eisele ($192,963.30), Karen Lewis ($957,418.90), Lukas Scheibler ($600,000.00), Mark Jeffrey Delong ($570,080.94), Nur Nicholson ($1,600,274.60), Pascal Deschatelets ($16,882,877.64), and Timothy Eugene Sullivan ($7,897,356.05). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,203,826 Apellis Pharmaceuticals shares in the last 24 months for a total of $70,524,594.64 sold. More Insider Trading Tools from MarketBeat Related Companies: Rigel Pharmaceuticals Insider Transactions Omeros Insider Transactions Seres Therapeutics Insider Transactions Genmab A/S Insider Transactions Summit Therapeutics Insider Transactions Viatris Insider Transactions Vaxcyte Insider Transactions Sarepta Therapeutics Insider Transactions Ginkgo Bioworks Insider Transactions Catalent Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:APLS) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.